In natural killer (NK) cells, CIS restrains a signaling pathway elicited by interleukin 15 (IL-15) that leads to activation of the kinase JAK1. Removal of CIS from NK cells increases their capacity to reduce the metastatic dissemination of breast cancer and melanoma in mice.
References
Vesely, M.D., Kershaw, M.H., Schreiber, R.D. & Smyth, M.J. Annu. Rev. Immunol. 29, 235–271 (2011).
Palucka, A.K. & Coussens, L.M. Cell 164, 1233–1247 (2016).
Delconte, R.B. et al. Nat. Immunol. 17, 816–824 (2016).
O'Sullivan, T. et al. J. Exp. Med. 209, 1869–1882 (2012).
Zitvogel, L. et al. Nat. Rev. Clin. Oncol. (in the press).
Galluzzi, L., Buqué, A., Kepp, O., Zitvogel, L. & Kroemer, G. Cancer Cell 28, 690–714 (2015).
Benson, D.M. Jr. et al. Clin. Cancer Res. 21, 4055–4061 (2015).
Blake, S.J. et al. Cancer Discov. 6, 446–459 (2016).
Aman, M.J. et al. J. Biol. Chem. 274, 30266–30272 (1999).
Yang, X.O. et al. Nat. Immunol. 14, 732–740 (2013).
Palmer, D.C. et al. J. Exp. Med. 212, 2095–2113 (2015).
Menger, L. et al. Blood 126, 2781–2789 (2015).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Zitvogel, L., Kroemer, G. Unchaining NK cell–mediated anticancer immunosurveillance. Nat Immunol 17, 746–747 (2016). https://doi.org/10.1038/ni.3471
Published:
Issue Date:
DOI: https://doi.org/10.1038/ni.3471
- Springer Nature America, Inc.